TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Visiopharm LRI AB
Closing information (x1000 DKK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
13,321
|
17,028 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
573
|
1,606 | |
| EBITDA |
487
|
1,606 | |
| Total assets |
13,180
|
10,569 | |
| Current assets |
13,171
|
10,569 | |
| Current liabilities |
6,575
|
3,964 | |
| Equity capital |
6,436
|
6,290 | |
| - share capital |
65
|
68 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
48.8%
|
59.5% | |
| Turnover per employee |
4,440
|
5,676 | |
| Profit as a percentage of turnover |
4.3%
|
9.4% | |
| Return on assets (ROA) |
4.3%
|
15.2% | |
| Current ratio |
200.3%
|
266.6% | |
| Return on equity (ROE) |
8.9%
|
25.5% | |
| Change turnover |
-2,899
|
-2,905 | |
| Change turnover % |
70%
|
-18%
|
-15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.